Gerbsman Partners focuses on maximizing enterprise value for under-valued, under-capitalized and under-performing companies and their Intellectual Property.
Since 2001, Gerbsman Partners has been involved in maximizing value for 79 Venture Capital and Senior Lender backed Technology, Life Science, Medical Device and Solar companies and their Intellectual Property. Gerbsman Partners has accomplished this through its targeted and proprietary “Date Certain M&A Process”. Gerbsman Partners has also restructured/terminated over $ 810 million of real estate executory contracts and equipment lease/sub-debt obligations.
Since inception, Gerbsman Partners has been involved in over $2.3 billion of financings, restructurings and M&A transactions.
Gerbsman Partners also seekss to identify valuable and leading edge Wireless and Web technologies and products from targeted companies in the US, Europe and Israel. Our objectives for these companies and their IP are to:
- Establish profitable relationships for M & A
- Promote partnerships and licensing
- Facilitate IP transfer
- Identify funding/expansion capital
Please visit www.gerbsmanpartners.com for additional information on services.